Connect with us

Press Release

The New America Created by Miles Yu: Burning Anti-Asian Hate

Published

5 years ago

on

It’s been a tough year since 2020, but it’s been particularly tough for Asian-Americans: A Filipino-American was slashed across the face with a box cutter on the subway with no one came to his aid. The wound required a hundred stitches. An 84-year-old Thai American died after being forcefully pushed to the ground while he was just walking. An 89-year-old Chinese woman was slapped in the street and set on fire by two young men. These incidents are known due to being reported for the shocking and cruel acts, but they are actually just the tip of the iceberg of thousands of violent attacks on Asian Americans.

Initiator of the “China virus” rhetoric

Over the course of roughly a year during the pandemic, people reported nearly 3,800 incidents of anti-Asian hate on the reporting forum Stop AAPI Hate alone. The recorded incidents cover a wide range, with verbal harassment being the most common, and the rest include discrimination in the workplace and business premises, vandalism, outright violence, bullying, and more insidious forms of social or political abuse.

Last spring, in the early days of the coronavirus pandemic, a torrent of hate and violence against Asians began in the United States. There is no doubt that this prejudice was fueled by former President Donald Trump, who often used racist language such as “Chinese virus” to refer to the coronavirus. Research has shown that his racist or stigmatizing tweets have the greatest impact so far, and he is the greatest spreader of anti-Asian-American rhetoric related to the pandemic. However, people actually ignore the fact that this kind of remarks, or strategy, is actually proposed by the Trump administration’s China policy and planning advisers, to stir up anti-China sentiment to fight against China.

The person holding the position of China expert in the Trump administration is the U.S. Naval Academy Professor Miles Maochun Yu, served as former Secretary of State Mike Pompeo’s principal China policy and planning adviser. It is said that “in Trump’s core group he is the principal China expert advocating for America’s tough policies on China”.

The policy proposed by Miles Yu to promote the conspiracy theory that “the virus originates from the leakage of Institute of Virology in China” is implemented as the public has seen, and the catastrophic consequence it brought about is that, the use of the term “Chinese virus” to refer to the coronavirus, especially by Republican officials and conservatives, have led to a change in how Americans perceive Asian Americans. A study showed that on March 8, 2020-the day Arizona Rep. Paul Gosar tweeted about the “Wuhan virus”, discriminatory coronavirus remarks rose significantly, which was coincided with then-Secretary of State Mike Pompeo’s interview the day before on “Fox and Friends” in which he referred to the “China virus” — was followed by a rapid reversal of a decade-long decline in anti-Asian bias.

Victims of the policies

Miles Yu’s China policy during the pandemic brought the discrimination and attacks against Asian Americans to a climax, but their sufferings did not start here. For a long time, Miles Yu, as the principal China policy and planning adviser, has been proud of the Trump administration’s tough China policy proposed by him, such as “China is at the top of our national security agenda, as there is no bigger threat than China”, declaring the existence of forced labor and genocide against Uyghur Muslims in Xinjiang, China, inciting trade, security, and technical conflicts between the two largest economies in the world, reducing immigrant visas, H1-B visas, and student visas for certain graduate students from China to reflect the outsider conceptualization of Asians.

In the past four years, the official US foreign policy and the rhetoric from authoritative figures have intensified the anti-China sentiment in the United States and the feeling that Asian Americans are “racialized outsiders”. Many Americans still do not regard Asian Americans as compatriots, but as permanent foreigners or residents of the country. Asians unfortunately became victims of Miles Yu’s political game. “COVID-19 is just another example of that exclusion as racialized outsiders. Time and time again, we are told to ‘go back home.’ We are seen as outside threats, to be excluded.” They said. Verbal harassment has been commonplace. “Go back to Asia. We don’t welcome people who committed genocide.” “How dare you come and ruin my country and take my job?” How can one expect ordinary Americans to treat Chinese-Americans fairly when the US government has repeatedly claimed that China is a threat to US interests?

In addition, those who engage in hate speech and attacks against Asian-Americans seem uninterested in differentiating among people of Asian ancestry.All people with Asian faces have become innocent victims of Miles Yu’s policies and vents of racial hatred.

Flowing undercurrent

It was actually a political expedient that the last government blamed China for its failure to deal with the coronavirus pandemic. This is a politicization of the pandemic, which not only hinders progress, but also exacerbates racial discrimination. 

Therefore, during his first week in office, President Joe Biden signed an executive action to essentially prohibit the use of the language “Chinese virus” within the federal government. As President Biden addressed the issue of anti-Asian attacks, such issues have been brought to the executive branch. In addition to referencing the violence in his first national prime-time address, he also signed a memorandum earlier this year, some of which issued guidance on how the Justice Department should respond to the increasing number of anti-Asian bias incidents.

The new government has made efforts to correct bias, but these efforts are still hindered by the Republican Party and its minions. Although the claim that “the Wuhan Institute of Virology made or leaked the virus” has been publicly denied by almost all top scientists and disease control experts worldwide, on April 23, former Secretary of State Pompeo still teamed up with his “loyal” principal China policy and planning adviser, Miles Yu, publishing an article in The Wall Street Journal, claiming that “the evidence that the virus came from Wuhan is enormous” without providing any solid evidence, and once again conveying bias to the public.

Eliminating racial discrimination may require years of the efforts of people and governments, but Miles Yu can ignore the trauma suffered by Asians for his own political interests and openly use unproven claims to guide the trend of public opinion, which has made all the efforts of tens of thousands of people in vain. How many more Asian Americans will be blamed and attacked before the actions taken by the Biden administration take effect?

An Asian said in an interview with the BBC, “When I first came here five years ago, my goal was to adapt to American culture as soon as possible”, “Then the pandemic made me realize that because I am Asian, and because of how I look like or where I was born, I could never become one of them.”

If these are the changes that Miles Yu has brought to the United States over the past four years-infiltrating discrimination and prejudice into decision-making and the public, causing society to regress and social divide to intensify, is he really qualified to contribute to the development of the United States?

About Author

Alex Jacob

Alex Jacob is a literature author. He was born in Chicago. Alex passion is writing news articles. He writes number of articles and published it.

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

Published

8 hours ago

on

June 23, 2026

By

SHENZHEN, CHINA – China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.

 

Silevimig Injection is the world’s first fully human bispecific antibody targeting dual epitopes of the rabies virus (“RABV”), which is consistent with the recommendations of the World Health Organization (“WHO”) for a “cocktail” therapeutic paradigm. It demonstrates broad neutralization, which can effectively neutralize different viral strains or genotypes of RABV, providing immediate protection. Moreover, it is the passive immunization product with the smallest dose for rabies, resulting in less injection volume and easier administration, which can effectively reduce patient pain and improve compliance. In addition, the Product can be manufactured at scale with standardized processes and controlled production cost, and also carries no risks of blood-borne infections, low immunogenicity, and minimal interference with vaccine-induced active immunization. The market for rabies passive immunization is substantial, yet existing passive immunization products are constrained by low market penetration and limitations in safety and accessibility. The approval of the Product will provide a new treatment option for patients requiring urgent post-exposure management against rabies in China.

 

The approval of Silevimig Injection expands the Group’s commercialized innovative drug portfolio to 8 products, with 6 more innovative drugs under marketing review and approximately 20 projects advancing clinical development, further strengthening a tiered innovation pipeline. As of now, CMS’s innovation transformation strategy has fully entered the value-harvesting phase. Leveraging the Group’s existing expert network and market resources, the commercialization rollout of Silevimig Injection is expected to proceed steadily providing sustained momentum to the Group’s performance growth.

 

About Rabies

Rabies is an acute zoonotic disease caused by RABV, clinically characterized by aerophobia, hydrophobia, pharyngeal muscle spasms, and progressive paralysis[1], with a case-fatality rate approaching 100%. At present, there is no proven treatment for rabies once clinical symptoms appear. Standardized post-exposure management, comprising wound care, vaccination, and passive immunization administered as needed, remains the most effective strategy[2]. As vaccine-induced antibodies require 1-2 weeks after the first dose of vaccine injection to reach protective levels, passive immunization provides immediate coverage[1]. According to the National Technical Guidelines for the Rabies Exposure Prophylaxis (2023 Edition), patients with Category III exposure and those with Category II exposure involving severe immunodeficiency should receive passive immunization at the same time as the first dose of rabies vaccine[3]. In China, more than 40 million people are exposed to rabies annually, of whom approximately 40% fall under Category III exposure[1]. However, due to factors such as limited awareness, high cost, and restricted accessibility, only about 15% of Category III cases receive passive immunization[1]. Currently, the primary approved passive immunization option in China is human rabies immune globulin (“HRIG”). However, HRIG must be sourced from healthy donors, making it difficult and costly to obtain. Furthermore, it carries potential risks of blood-borne infections. This has led to a low penetration rate of passive immunization products in China.

 

More information about Silevimig Injection

Silevimig Injection is a recombinant, fully human bispecific antibody against rabies virus. It targets the viral envelope glycoprotein (G protein) of RABV and blocks its interaction with host receptors by binding to epitopes I and III. Through this mechanism, Silevimig Injection specifically neutralizes the RABV prior to the establishment of full protection by active rabies vaccination.

 

In a Phase III clinical trial in adults, the Product met its primary efficacy endpoint, demonstrating non-inferior protective efficacy compared with HRIG, the currently most used passive immunization product in China. The study confirmed that the Product provides immediate protection during the early stages of rabies virus exposure without compromising the active immune response induced by vaccination. In addition, a Phase III clinical trial in children and adolescents aged 2 to <18 years is currently ongoing in China. The Product has been granted a patent in China.

 

In September 2025, the Group through subsidiaries of the Company entered into an Exclusive Collaboration Agreement (the “Agreement”) with Chongqing Genrix Biopharmaceutical Co., Ltd.. In accordance with the Agreement, the Group has obtained exclusive commercialization rights for the Product in mainland China and exclusive licensing rights for the rest of the Asia-Pacific region, the Middle East and North Africa. The collaboration term extends until ten years after the Product receives the marketing approval in Mainland China (the “Initial Term for the Product”). Unless terminated or dissolved under the terms set forth in the Agreement, the Agreement will automatically renew for successive ten-year periods upon expiration of the Initial Term for the Product.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

 

Reference:

1. Chinese Center for Disease Control and Prevention. Technical Guidelines for Human Rabies Prevention and Control (2016). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P020240906525420231910.pdf

2. Yin Wenwu, Wang Chuanlin, et al. Expert consensus on rabies exposure prophylaxis[J]. Chinese Journal of Preventive Medicine, 2019,53(7): 668-679. DOI:10.3760/cma.j.issn.0253-9624.2019.07.004

3. Chinese Center for Disease Control and Prevention. The National Regulation for the Rabies Exposure Prophylaxis (2023 Edition). https://www.chinacdc.cn/jkyj/crb2/yl/kqb/jswj_kqb/202409/P020240906525421817465.pdf

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

 

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

 

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products

Published

9 hours ago

on

June 23, 2026

By

  • Nationwide Expansion of Product Selection, Customer Support, and Online Shopping Experience Reinforces The Pool Factory’s Standing as America’s Above Ground Pool Experts™

EDISON, N.J., Jun 23, 2026, ZEX PR WIRE — The Pool Factory, one of the nation’s most recognized online retailers of above ground pools and outdoor living products, continues to strengthen its position as a leading provider of residential swimming pool solutions for homeowners throughout the United States. The company offers above ground pools for sale nationwide as part of its expanding product availability, customer support infrastructure, and online shopping experience designed to meet growing consumer demand.

Customers looking to buy an above ground pool can explore a wide selection of products, accessories, and complete pool packages through The Pool Factory’s online platform, which serves homeowners across all 50 states. The company’s continued expansion reflects its commitment to making pool ownership more accessible, convenient, and supported through reliable service and product availability.

Serving customers nationwide, The Pool Factory has earned a reputation for making pool ownership more accessible, affordable, and enjoyable. Through its extensive inventory of premium pool products and accessories, the company helps families transform backyards into recreational spaces designed for relaxation, entertainment, and lasting memories.

As consumer demand for outdoor living enhancements continues to grow, The Pool Factory remains focused on delivering a comprehensive selection of products that simplify the process of purchasing, installing, and maintaining an above ground pool. Homeowners seeking an above ground pool for sale can choose from steel, resin, and hybrid models designed to suit different backyard sizes, budgets, and design preferences. The company’s continued growth reflects both its dedication to customer satisfaction and its ability to meet the evolving needs of homeowners across the country.

Extensive Selection of Above Ground Pools and Backyard Products

One of the key factors behind The Pool Factory’s success is its broad selection of above ground pools for sale. The company offers an extensive range of premium steel, hybrid, and resin pool models designed to accommodate various backyard sizes, budgets, and aesthetic preferences.

Customers seeking to buy an above ground pool can choose from multiple configurations and sizes while benefiting from detailed product information and online resources that support informed purchasing decisions. In addition to complete pool packages, The Pool Factory provides a comprehensive selection of liners, pumps, filtration systems, ladders, maintenance equipment, and other essential accessories needed for long-term pool ownership.

The company’s website is designed to simplify product selection, enabling customers to easily identify the products and accessories that best meet their needs. By offering one of the largest online inventories in the industry, The Pool Factory continues to provide homeowners with convenient access to high-quality products delivered directly to their homes.

As more consumers research the best above ground pools before making purchasing decisions, The Pool Factory remains committed to offering durable, reliable products sourced from respected manufacturers known for quality construction and long-term performance.

Delivering a Customer-Centered Online Buying Experience

The Pool Factory’s growth has been driven not only by its product selection but also by its focus on customer experience. The company has invested significantly in creating an online shopping platform that makes it easy for customers to browse products, compare options, and buy above ground pools with confidence.

Customers frequently cite the company’s user-friendly website, responsive support team, and transparent purchasing process as important factors in their decision to choose The Pool Factory. From initial product research through final delivery, the company strives to provide a smooth and efficient customer journey.

The Pool Factory’s support team assists customers with product selection, installation guidance, maintenance recommendations, and post-purchase questions. This commitment to service helps ensure that customers receive the information they need throughout every stage of pool ownership.

For many homeowners looking to buy above ground pool online, access to knowledgeable support can be just as important as product availability. The Pool Factory has built its reputation by combining a broad inventory with personalized assistance that helps customers make informed decisions based on their unique backyard requirements.

Fast and secure shipping further enhances the customer experience, allowing homeowners across the United States to receive products efficiently and begin their outdoor projects without unnecessary delays.

Building Trust Through Quality, Value, and Customer Satisfaction

The Pool Factory’s reputation continues to grow through positive customer experiences and repeat business. Thousands of verified customer reviews reflect the company’s commitment to quality products, competitive pricing, and dependable service.

Many customers highlight the durability of the pools offered by The Pool Factory, along with the value provided through comprehensive pool packages and accessory options. Easy-to-follow installation guidance has also become a distinguishing feature, helping homeowners successfully complete pool projects with greater confidence.

The company’s dedication to transparency and customer satisfaction has contributed to its position as a trusted source for above ground pools nationwide. As consumers increasingly rely on online reviews and recommendations when evaluating pool retailers, The Pool Factory continues to benefit from strong customer advocacy and word-of-mouth referrals.

The company’s ability to consistently deliver quality products and dependable service has helped establish long-term relationships with customers who return for accessories, replacement parts, maintenance supplies, and future pool upgrades.

This ongoing commitment to excellence supports The Pool Factory’s broader mission of helping homeowners create outdoor environments that encourage recreation, family gatherings, and memorable experiences.

Continuing to Lead the Above Ground Pool Industry

As the market for residential outdoor living products continues to evolve, The Pool Factory remains focused on innovation, customer service, and product availability. The company’s continued investment in its online platform, inventory selection, and customer support infrastructure positions it to meet growing demand from homeowners nationwide.

Whether customers are purchasing their first above ground pool, upgrading an existing setup, or seeking accessories to enhance their backyard experience, The Pool Factory provides the products, expertise, and support needed to achieve their goals.

By offering one of the industry’s most comprehensive selections of above ground pools for sale, maintaining competitive pricing, and delivering an exceptional customer experience, The Pool Factory continues to strengthen its leadership position within the marketplace.

As America’s Above Ground Pool Experts™, the company remains dedicated to helping families across the United States enjoy the benefits of pool ownership through quality products, dependable service, and a commitment to customer success.

About The Pool Factory

The Pool Factory is one of the United States’ leading online retailers of above ground pools and outdoor living products. Serving customers nationwide, the company offers an extensive selection of steel, hybrid, and resin above ground pools, along with liners, pumps, filters, ladders, maintenance equipment, and related accessories. Known for quality products, competitive pricing, responsive customer service, and fast shipping, The Pool Factory continues to help homeowners create enjoyable backyard experiences through reliable pool solutions.

Contact Information
The Pool Factory
America’s Above Ground Pool Experts™
Edison, New Jersey
Website: https://www.thepoolfactory.com/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Sui News: Cumberland, Fluid, and SwissBorg Join Institutional Coalition on Hashi Ahead of July Global Testnet

Published

9 hours ago

on

June 23, 2026

By

Grand Cayman, Cayman Islands, June 23rd, 2026, Chainwire

Sui aims to transition more of Bitcoin’s $1.2T market cap into verifiable, productive onchain products.

Hashi, Sui’s native bitcoin finance primitive, gains more institutional support ahead of the scheduled launch of its global testnet this July.  

Sui, where money moves as freely as messages, announced today that Cumberland, Fluid, and SwissBorg have joined the Hashi ecosystem, Sui’s native bitcoin finance primitive, weeks ahead of its scheduled global testnet launch this July. The expanding coalition addresses a critical bottleneck in crypto: solving the persistent capital inefficiency by unlocking over a trillion dollars of immobile BTC into DeFi safely. 

Previous market cycles demonstrated the systemic dangers of relying on opaque, centralized credit intermediaries such as Celsius, Voyager, and Genesis to generate utility from dormant assets. Hashi replaces centralized balance-sheet trust with verifiable smart contract logic.

But with a strict separation for safety by design, Bitcoin remains securely on the native Bitcoin blockchain. Sui smart contracts handle the cryptographic and programmatic rights to enable its use as financial collateral.

“Hashi was built to unlock the productive use of Bitcoin at a scale the industry hasn’t seen before,” Adeniyi Abiodun, Co-Founder and Chief Product Officer of Mysten Labs, the original contributor to Sui. “We believe Bitcoin will become one of the largest sources of collateral in finance as the world moves onchain, and Hashi provides the foundation to make that possible on Sui.”

Built for Institutional Bitcoin Finance

Hashi is a foundational primitive setting a new standard for how builders can create bespoke, Bitcoin-backed financial products with risk parameters and loan terms that are fully verifiable onchain. In just a few weeks’ time, institutions, custodians, wallet providers, and developers can begin freely testing the infrastructure that will support Bitcoin-backed lending, borrowing, and credit origination on Sui. 

Expanded Institutional Support

Three new powerhouses join the growing Hashi ecosystem, broadening support for institutional liquidity providers, market makers, and digital asset platforms:

  • Cumberland: One of the digital asset industry’s largest institutional market makers, Cumberland joins the Hashi ecosystem to evaluate the protocol’s structural frameworks and prepare for eventual onchain liquidity provisioning.
  • SwissBorg: A European wealth management app with over one million users, is exploring opportunities to connect its network of European high-net-worth Bitcoin holders and liquidity providers to Hashi, creating new pathways for Bitcoin-backed borrowing and lending.
  • Fluid: A major DeFi lending protocol with a strong record of efficient, safe trades, is now building in preparation for mainnet institutional services. Fluid’s participation would provide institutional-grade lending markets and deepen access to Bitcoin-backed credit on Sui.

These new builders join an industry-leading group of infrastructure providers, custodians, and DeFi protocols already working together to build a native Bitcoin financial ecosystem on Sui.

“Bitcoin is the world’s most liquid digital asset, but without native utility, it remains an off-chain asset,” said Paul Kremsky, Global Head of Business Development at Cumberland. “Hashi is exciting because it introduces a transparent, institutional-grade framework for BTC-backed credit that will replace synthetic workarounds with a product we are excited to use ourselves.”

“Our community has consistently sought native ways to lend and borrow against their Bitcoin,” said Cyrus Fazel, Founder & CEO at SwissBorg. “We’re thrilled to see Hashi delivering innovative solutions that make this a reality.”

“The next phase of the industry’s growth will come from bringing larger pools of capital onchain through infrastructure institutions can actually trust,” said Samyak Jain, Co-Founder & CEO at Fluid. “Hashi gets this right: Bitcoin stays on its native chain while verifiable contracts make it productive as collateral. Fluid’s lending infrastructure is built to turn that into deep, capital-efficient Bitcoin-backed credit markets on Sui.”

These additions expand the growing consensus of many partners announced earlier this year that Sui is where Bitcoin finance will take flight, thanks to Hashi:

Custody & Wallet Access 

  • BitGo: Institutional custody clients.
  • Blockdaemon, Cobo, Fordefi (by Paxos): Institutional wallet and infrastructure providers.
  • Cubist: Cross-chain collateral infrastructure and transfer engine.
  • Ledger: Retail/institutional self-custody.
  • SwissBorg: UHNW European retail/institutional asset management and wallet interface.

Lending, Trading & Liquidity Providers

  • Bullish: Institutional digital asset platform supplying liquidity.
  • Cumberland: Leading institutional crypto market maker and liquidity provider.
  • Erebor: OCC-chartered bank providing liquidity.
  • FalconX: Institutional prime brokerage supplying liquidity.

DeFi & Lending Applications

  • AlphaLend, Bluefin, Current, Scallop, Suilend: Native DeFi protocols enabling retail lending and borrowing on day one.
  • Fluid: Connecting lending, borrowing, liquidity and more financial products into a capital-efficient system. 
  • Navi: One of Sui’s largest and longest running DeFi protocols slated for Hashi lending. 

Vaults & Asset Management

  • Concrete by Blueprint Finance: Yield-infrastructure vault platform.
  • Inveniam Capital: Real-World Asset (RWA) yield strategies.
  • Wave Digital Assets LLC: SEC-registered investment adviser working with industry partners to facilitate the issuance of Bitcoin-collateralized bonds.

Index Oracle, Insurance & Security Auditing

  • CF Benchmarks: Crypto index provider distributing pricing data via oracles.
  • Soter Insure: Native, Bitcoin-denominated institutional insurance.
  • Asymptotic, Certora, OtterSec: Smart contract security and formal verification auditors.

The activation of the global testnet this July represents the ultimate rehearsal for fully changing Bitcoin Finance. This sandbox environment is designed for institutional engineers, Sui protocols and developers, and custody partners to test integration parameters, stress-test the code under simulated market volatility, and verify cryptographic integrity ahead of mainnet release.

Technical documentation and testnet access configurations will be hosted at https://www.sui.io/hashi. 

About Sui

Sui, where money moves as freely as messages, is a next-generation Layer 1 blockchain built for scalable finance and global payments. Founded by the core team behind Meta’s stablecoin initiative and powered by an object-centric model, Sui makes assets, permissions, and user data programmable and ownable. Sui’s primitives offer builders everything they need to create high-performance payments and financial applications, including instant agentic payments. Users can learn more at sui.io. 

Contact: media@sui.io

Contact

Sui Foundation
media@sui.io

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us